ATC code A12
| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Drugs for constipation |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
ATC code A12 Mineral supplements is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup A12 is part of the anatomical group A Alimentary tract and metabolism.[3]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA12.[4] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A12A Calcium[edit]
A12AA Calcium[edit]
- A12AA01 Calcium phosphate
- A12AA02 Calcium glubionate
- A12AA03 Calcium gluconate
- A12AA04 Calcium carbonate
- A12AA05 Calcium lactate
- A12AA06 Calcium lactate gluconate
- A12AA07 Calcium chloride
- A12AA08 Calcium glycerylphosphate
- A12AA09 Calcium citrate lysine complex
- A12AA10 Calcium glucoheptonate
- A12AA11 Calcium pangamate
- A12AA13 Calcium citrate
- A12AA20 Calcium (different salts in combination)
- A12AA30 Calcium laevulate
A12AX Calcium, combinations with vitamin D and/or other drugs[edit]
A12B Potassium[edit]
A12BA Potassium[edit]
- A12BA01 Potassium chloride (medical use)
- A12BA02 Potassium citrate
- A12BA03 Potassium hydrogentartrate
- A12BA04 Potassium hydrogencarbonate
- A12BA05 Potassium gluconate
- A12BA30 Potassium (different salts in combination)
- A12BA51 Potassium chloride, combinations
A12C Other mineral supplements[edit]
A12CA Sodium[edit]
- A12CA01 Sodium chloride or saline (medicine)
- A12CA02 Sodium sulfate
A12CB Zinc[edit]
- A12CB01 Zinc sulfate
- A12CB02 Zinc gluconate
- A12CB03 Zinc protein complex
A12CC Magnesium[edit]
- A12CC01 Magnesium chloride
- A12CC02 Magnesium sulfate (medical use)
- A12CC03 Magnesium gluconate
- A12CC04 Magnesium citrate
- A12CC05 Magnesium aspartate
- A12CC06 Magnesium lactate
- A12CC07 Magnesium levulinate
- A12CC08 Magnesium pidolate
- A12CC09 Magnesium orotate
- A12CC10 Magnesium oxide
- A12CC30 Magnesium (different salts in combination)
A12CD Fluoride[edit]
- A12CD01 Sodium fluoride
- A12CD02 Sodium monofluorophosphate
- A12CD51 Fluoride, combinations
A12CE Selenium[edit]
- A12CE01 Sodium selenate
- A12CE02 Sodium selenite
- QA12CE99 Selenium, combinations
A12CX Other mineral products[edit]
- QA12CX90 Toldimfos
- QA12CX91 Butafosfan
- QA12CX99 Other mineral products, combinations
References[edit]
- ↑ ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). National Institutes of Health.
- ↑ ATC-Klassifikation mit definierten Tagesdosen DDD(link). German Institute for Medical Documentation and Information.
- ↑ ATC/DDD Index 2022
- code A12(link). WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ ATCvet Index 2022
- code QA12(link). WHO Collaborating Centre for Drug Statistics Methodology.
| Mineral supplements (A12) | ||||||
|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian